Your browser doesn't support javascript.
Progress in the Research and Development of Anti-COVID-19 Drugs.
Huang, Lianzhou; Chen, Yuanqiu; Xiao, Ji; Luo, Weisheng; Li, Feng; Wang, Yuan; Wang, Yiliang; Wang, Yifei.
  • Huang L; Guangzhou Jinan Biomedicine Research and Development Center, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Chen Y; Guangzhou Jinan Biomedicine Research and Development Center, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Xiao J; Guangzhou Jinan Biomedicine Research and Development Center, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Luo W; Guangzhou Jinan Biomedicine Research and Development Center, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Li F; Guangzhou Jinan Biomedicine Research and Development Center, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Wang Y; Guangzhou Jinan Biomedicine Research and Development Center, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Wang Y; Guangzhou Jinan Biomedicine Research and Development Center, College of Life Science and Technology, Jinan University, Guangzhou, China.
  • Wang Y; Guangzhou Jinan Biomedicine Research and Development Center, College of Life Science and Technology, Jinan University, Guangzhou, China.
Front Public Health ; 8: 365, 2020.
Article in English | MEDLINE | ID: covidwho-690601
ABSTRACT
The outbreaks of COVID-19 due to SARS-CoV-2 has caused serious physical and psychological damage to global human health. COVID-19 spread rapidly around the world in a short time. Confronted with such a highly infectious respiratory disease, the research and development of anti-COVID-19 drugs became an urgent work due to the lack of specific drugs for the treatment of COVID-19. Nevertheless, several existing drugs are available to relieve the clinical symptoms of COVID-19. We reviewed information on selected anti-SARS-CoV-2 candidate therapeutic agents published until June 2, 2020. We also discussed the strategies of the development of anti-COVID-19 drugs in the future. Our review provides a novel insight into the future development of a safer, efficient, and toxic-less anti-COVID-19 drug.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pharmaceutical Preparations / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Front Public Health Year: 2020 Document Type: Article Affiliation country: Fpubh.2020.00365

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pharmaceutical Preparations / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Front Public Health Year: 2020 Document Type: Article Affiliation country: Fpubh.2020.00365